NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 5,760.00
-540.00 (-8.57%)
Oct 15, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 70.27 billion as of October 15, 2026. It is the 29,876th most valuable company in the world and the 1,542nd biggest in South Korea. Its market cap has decreased by 68.16% in one year.
Market Cap
70.27B
Enterprise Value
31.99B
Revenue
2.59B
Global Rank
Country Rank
#1,542 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 70.27B, a decrease of -69.84%. That is a compound annual growth rate of -62.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 70.27B | -72.86% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 55.76T |
| Celltrion | 41.05T |
| ALTEOGEN | 15.63T |
| Samsung Epis Holdings | 7.81T |
| Osang Healthcare Co.,Ltd | 83.47B |
| CMG Pharmaceutical | 83.25B |
| DK Life Science | 80.92B |
| Enzychem Lifesciences | 76.86B |